Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.7% | 16.2% | 5.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -342% | -307.4% | -339.3% | -337.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -362.7% | -333.1% | -370.5% | -352.2% |
| EPS Diluted | -0.21 | -0.17 | -0.16 | -0.15 |
| % Growth | -23.5% | -6.3% | -6.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |